BACH PHARMA, INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for BACH PHARMA, INC..The latest application filed is for "compositions and methods for treating brain dysfunction".

Company Profile

0.10.10

BACH PHARMA, INC. - North Andover MA US
BACH PHARMA, INC - NORTH ANDOVER MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Compositions And Methods For Treating Brain Dysfunction App 20210161890 - Henry; Mark O. ; et al.	2021-06-03
Modulation Of Cell Fates And Activities By Phthalazinediones App 20180153889 - Henry; Mark O. ; et al.	2018-06-07
Modulation of cell fates and activities by phthalazinediones Grant 9,968,602 - Henry , et al. May 15, 2	2018-05-15
Process for preparing 5-amino-2,3-dihydrophthalazine-1,4-dione monosodium salt Grant 9,732,043 - Henry , et al. August 15, 2	2017-08-15
Pharmaceutical Grade Phthalazinediones, Process For Their Preparation And Pharmaceutical Compositions Containing Them App 20160237039 - Henry; Mark O. ; et al.	2016-08-18
Method for treating neurodegeneration using a p38MAPK inhibitor Grant 9,358,225 - Wong June 7, 2	2016-06-07
Methods of treating intestinal diseases and inflammatory conditions related to HIV-AIDS Grant 8,895,555 - Henry , et al. November 25, 2	2014-11-25
Methods Of Treating Intestinal Diseases And Inflammatory Conditions Related To Hiv-aids App 20100255077 - HENRY; Mark O. ; et al.	2010-10-07
Pharmaceutical Grade Phthalazinediones, Process For Their Preparation And Pharmaceutical Compositions Containing Them App 20100222584 - HENRY; Mark O. ; et al.	2010-09-02
METHODS OF MODULATING PROTEIN HOMEOSTASIS, METABOLIC SYNDROME, HEAVY METAL INTOXICATION AND Nrf2 TRANSCRIPTION FACTORS App 20100086531 - Henry; Mark O. ; et al.	2010-04-08
Modulation of cell fates and activities by phthalazinediones Grant 7,691,819 - Henry , et al. April 6, 2	2010-04-06
Modulation Of Cell Fates And Activities By Phthalazinediones App 20090036411 - Henry; Mark O. ; et al.	2009-02-05
Modulation Of Cell Fates And Activities By Phthalazinediones App 20090018137 - Henry; Mark O. ; et al.	2009-01-15
Modulation of cell fates and activities by phthalazinediones Grant 7,326,690 - Henry , et al. February 5, 2	2008-02-05
Modulation of cell fates and activities by phthalazinediones App 20070142303 - Henry; Mark O. ; et al.	2007-06-21
Modulation of cell fates and activities by phthalazinediones App 20050288291 - Henry, Mark O. ; et al.	2005-12-29
Modulation of cell fates and activities by diketo phthalazines Grant 6,953,799 - Henry , et al. October 11, 2	2005-10-11

Company Registrations

NCAGE Code	5Z8W8	BACH PHARMA, INC.
CAGE Code	5Z8W8	BACH PHARMA, INC.
S.A.M. Registration	5Z8W8 [157457024]	BACH PHARMA, INC.
SEC	0001430649	BACH PHARMA INC of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.